KRAS and familial pancreatic carcinoma: Through the study of the KRAS downstream signaling pathway, selective activation of the RAS-RAF-MEK-ERK signaling pathway can induce PanIN and pancreatic cancer development, and the RAS-RAF-MEK-ERK signaling cascade is the key to PDAC development, maintenance and treatment [55].